KR900000086A - Pharmaceutical composition of the target compound and its preparation - Google Patents

Pharmaceutical composition of the target compound and its preparation Download PDF

Info

Publication number
KR900000086A
KR900000086A KR1019890008354A KR890008354A KR900000086A KR 900000086 A KR900000086 A KR 900000086A KR 1019890008354 A KR1019890008354 A KR 1019890008354A KR 890008354 A KR890008354 A KR 890008354A KR 900000086 A KR900000086 A KR 900000086A
Authority
KR
South Korea
Prior art keywords
weight
primycin
pharmaceutical
composition
aqueous suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019890008354A
Other languages
Korean (ko)
Inventor
제드 스챠보 안나
갈 죠세프
마르마로시 니 켈너 카타린
세베스티엔 기울라
미호릭스 기젤라
코박스 마르타
Original Assignee
기율라 스주크, 타마스 스주츠
치노인 교기스져 에스 베게스제티 테트메케크 기야라 알티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기율라 스주크, 타마스 스주츠, 치노인 교기스져 에스 베게스제티 테트메케크 기야라 알티 filed Critical 기율라 스주크, 타마스 스주츠
Priority to KR1019890008354A priority Critical patent/KR900000086A/en
Publication of KR900000086A publication Critical patent/KR900000086A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음No content

Description

목적화합물의 약학적 조성과 그 제조방법.Pharmaceutical composition of the target compound and its preparation method.

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (9)

주성분으로서, 프리마이신 0.2-5중량%, 프로필렌글리콜5-25중량%, 비이온성 표면활성제 0.5-5중량%과 바람직하다면 보조제 15중량%와 증류수를 가해서 100중량%로 만든 한정화된 수성 현탁유상액.As a main component, a limited aqueous suspension emulsion made from 0.2-5% by weight of primycin, 5-25% by weight of propylene glycol, 0.5-5% by weight of nonionic surfactant and, if desired, 15% by weight of auxiliary and distilled water to 100% by weight. . 제1항에서, 라우릴, 세틸, 스테아릴 혹은 올레일 알콜로 형성된 폴리에칠글리콜의 에테르와 소르비탄지방산 에스테르 혹은 에톡시레이티드 스테아릴-알콜을 비이온성 표면활성제로 함유한 조성물.The composition of claim 1, wherein the ether of polyethylglycol formed of lauryl, cetyl, stearyl or oleyl alcohol and sorbitan fatty acid ester or ethoxylated stearyl-alcohol as nonionic surfactants. 제1항에서, 10㎛이하의 입자크기의 프리마이신을 함유한 조성물.The composition of claim 1 containing primycin having a particle size of 10 μm or less. 일반적으로 제약 혹은 제약-화장품 조성물에서 사요되는 충진, 희석 및/또는 다른 보조제를 0-20중량% 및 제1항에서의 프리마이신-함유 안정수성 현탁유상액을 주성분으로 50-100중량%로 함유하는 향균제 조성물.Filling, dilution and / or other adjuvants, generally used in pharmaceutical or pharmaceutical-cosmetic compositions, containing 0-20% by weight and 50-100% by weight of the primycin-containing stable aqueous suspension emulsion according to claim 1 as a main component. Antimicrobial composition. 일반적으로 제약 혹은 제약-화장품 조성물에서 사용되는 충진, 희석 및/또는 다른 형성 부속제를 0-20중량% 및 제1항에서의 프리마이신-함유 안정수성 현탁유상액을 주성분으로 50-99.8중량%로 함유하고 기지의 향균제를 0.2-5중량%로 함유하는 향균제 조성물.0-20% by weight of filling, dilution and / or other forming additives generally used in pharmaceutical or pharmaceutical-cosmetic compositions and 50-99.8% by weight of the primycin-containing stable aqueous suspension emulsion according to claim 1. An antimicrobial composition, which is contained in an amount of 0.2-5% by weight. 제4항 혹은 제5항에서, 주성분으로서 프리마이신 0.2-4.5중량%, 프로필렌글리콜12.5-23중량%, 비이온성 표면활성제 0.8-2.3중량%, 기지의 향미생물제 0-2중량%, 10-20중량%의 포움(foam)형상체와 증류수를 가해서 100중량%로 만든 상처부위 치료를 위한 주성분의 조절된 매개로써의 균절한 포움(foam)제.The method according to claim 4 or 5, 0.2-4.5% by weight of primycin, 12.5-23% by weight of propylene glycol, 0.8-2.3% by weight of nonionic surfactant, 0-2% by weight of known flavoring agents, 10-20 A uniform foaming agent as a controlled mediator of the main component for the treatment of wounds made by adding 100% by weight of foam and distilled water. 최종생성물로 환산한 프리마이신 0.2-5중량%, 프로필렌글리콜5-25중량%에 가온하에 용해 또는 현탁시킨후, 다음에 얻어진 용액 또는 현탁액을 비이온성 표면활성제 0.5-5중량%와 냉각하 또는 가온하에 혼합하고, 기타 보조제 0-15중량%를 가한후 다음에 필요량의 물을 가하여 100중량%로 하여, 활성성분으로 프리마이신을 함유하는 청구범위 제1,2 및 3의 안정한 수성현탁 유상액을 제조하는 방법.After dissolving or suspending 0.2-5% by weight of primycin and 5-25% by weight of propylene glycol as a final product, the resulting solution or suspension was then cooled or warmed with 0.5-5% by weight of nonionic surfactant. Under the addition of 0-15% by weight of other auxiliaries and then 100% by weight of the required amount of water to prepare the stable aqueous suspension emulsions of claims 1, 2 and 3 containing primycin as active ingredient. How to manufacture. 주성분으로써, 프리마이신을 함유하는 안정한 수성 현탁 유상액을 일반적으로 사용되는 충진, 희석 및/또는 다른 보조제와 바람직하다면 다른 기지의 향미생물제를 가한 제약 및/혹은-화장품 조성으로 전환한 제4항 혹은 제5항의 향균 조성물의 제조방법.4. As a main component, a stable aqueous suspension emulsion containing primycin has been converted to a pharmaceutical and / or cosmetic composition which has been added to commonly used filling, dilution and / or other auxiliaries and, if desired, other known flavoring agents. The manufacturing method of the antimicrobial composition of Claim 5. 제8항에서, 겔, 연고, 포움(foam)에어로졸, 혹은 반창고나 또는 프라스터와 같은 다른 국소 사용가능한 약제 형태의 조성물로 제형화하는 방법.The method of claim 8, formulated into a composition in the form of a gel, ointment, foam aerosol, or other topically available pharmaceutical form, such as a bandage or praster. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890008354A 1988-06-16 1989-06-16 Pharmaceutical composition of the target compound and its preparation Withdrawn KR900000086A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890008354A KR900000086A (en) 1988-06-16 1989-06-16 Pharmaceutical composition of the target compound and its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU22513088/88 1988-06-16
KR1019890008354A KR900000086A (en) 1988-06-16 1989-06-16 Pharmaceutical composition of the target compound and its preparation

Publications (1)

Publication Number Publication Date
KR900000086A true KR900000086A (en) 1990-01-30

Family

ID=67840848

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890008354A Withdrawn KR900000086A (en) 1988-06-16 1989-06-16 Pharmaceutical composition of the target compound and its preparation

Country Status (1)

Country Link
KR (1) KR900000086A (en)

Similar Documents

Publication Publication Date Title
AU692486B2 (en) Pharmaceutical or veterinary composition comprising mupirocin or a salt thereof in a cream base
CA1041011A (en) Anhydrous candicidin foam compositions
US4331653A (en) Composition for a topical cream for curtailing bleeding and treating skin disorders
CA1176979A (en) Antiherpetically active lipstick and the use thereof for the treatment of disorders of the lips and other areas of the face caused by human herpes viruses
KR840006440A (en) Preparation method of topical external pharmaceutical composition
EP0331489B1 (en) Acne treatment
US4166108A (en) Styptic composition
NO974023D0 (en) Topically Applicable Pharmaceutical Preparation, Process for its Preparation and Use
JPH02500358A (en) therapeutic pharmaceutical compositions
JPS60231604A (en) Insecticidal aqueous microemulsion composition
CA1238276A (en) Betamethasone dipropionate cream
KR910700002A (en) New concentrated aqueous emulsion, method for its preparation and use as pesticide
US3119739A (en) Acetylmethyl-salicylate for pain relief
KR900000086A (en) Pharmaceutical composition of the target compound and its preparation
GB2215205A (en) Skin treatment formulations comprising boric acid and/or perborate salt
US2771395A (en) Aqueous alcoholic hair grooming preparation employing sodium carboxymethyl cellulose
RU2148998C1 (en) Pharmaceutical or veterinary composition (variants) and method of composition preparing
KR970701991A (en) Novel Pesticide Compositions and Mothod of Preparation
RU2116073C1 (en) Pharmaceutical ointment not showing irritant effect on skin and a method of its preparing
FI56486C (en) FOERFARANDE FOER FRAMSTAELLNING AV EN UREA PHARMACEUTICAL COMPOSITION TILL ANVAENDNING FOER UTVAERTES BRUK PAO MAENNISKOKUD
US3203854A (en) Fungicide and bactericide comprising the reaction product of 2, 4, 5-trichlorophenol and butyl phosphate
Peel OINTMENT BASES.
RU2139706C1 (en) Shaving agent
KR960700703A (en) STABLE MYCOPHENOLIC ACID-CONTAINING COMPOSITION FOR EPIDERMIC APPLICATION
IE47172B1 (en) Improved styptic composition

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890616

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid